Modified chemotherapy regimen for Hodgkin lymphoma reduces long-term side effects

A simple change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts that can result from treatment, according to researchers in Cambridge.

Ontada, Datavant Partner to Accelerate Oncology Innovation

What You Should Know: – Ontada, a McKesson business specializing in real-world data and clinical technology for community oncology, has announced a strategic collaboration with

November 12, 2024

ATMA Welcomes Dr. Scott Shannon, MAPS MDMA Phase 3 Principal Investigator, to Expand Its’ Clinical Training Expertise in MDMA-Assisted Therapy | Psychedelic Invest

Dr. Shannon will provide valuable expertise towards MDMA-Assisted Therapy Training from a MAPS clinical protocols foundation. ATMA Journey Centers Inc. (“ATMA”), a Canadian company with

October 25, 2023

Investors anticipate “bounce-back” in European private investment – Pharmaceutical Technology

Share this article At the Swiss Biotech Day conference, experts anticipated a recovery in the investment market. Credit: Scharvik via Getty Images The Swiss biotech

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.